Ilya Tsimafeyeu, Andrey Lebedinets, Makhabbat Murzalina, Alexander Zhuravlev, Vera Peryshkina, Milyausha Mukhitova, Petr V. Bulychkin. "A randomized phase 2 trial of lenvatinib plus pembrolizumab with or without stereotactic body radiotherapy in patients with metastatic renal cell carcinoma, low tumor burden, and stable disease (LASER).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.7_suppl.tps583